Research Services

Southwest CARE Center has a dedicated research team that has established a reputation nationally and internationally for its research program. The research team is comprised of our medical director, a research coordinator, a research nurse, a research administrator, and a clinical research assistant. This team makes it possible for us to continue to participate in industry sponsored clinical drug trials to provide patients with access to potentially life saving treatments. The team also develops investigator-initiated programs that explore treatment issues in FDA approved therapies.

The primary objective of our research program is to provide treatment to clients who have run out of options. Other objectives include: exploring potential interactions between FDA approved drugs and the clinical implications of these interactions. We have also been involved in studies examining the risks and benefits of using particular HIV antiretroviral regimens, as well as a state-wide study examining the impact of Adverse Childhood Events on Health Risk Behaviors in people who are HIV positive.

Southwest CARECenter has developed a research program that includes Phase I, II, and III trials. We have also participated in Expanded/Early Access programs for many drugs including Reyataz, Fuzeon, Viread, Kaletra, Preveon, Agenerase, Ziagen, Sustiva, Viracept, Epivir, and Zerit. In recent years we have participated in trials examining the potency of new classes of drugs including Fuzeon, CCR5 inhibitors and Integrase inhibitors as well as new Protease and Non-Nucleoside Reverse Transcriptase Inhibitors. Future projects include Intense Pharmacokinetic trials looking at interactions between approved agents as well as comparisons of relative side effect profiles of particular HIV regimens.

Though the primary objective of the Southwest CARECenter Research program is to provide our patients with state-of-of-the-art medical care, we have also had our work published in peer reviewed HIV medical journals like JAIDS, the Journal of Acquired Immunodefiecency Syndrome, and at leading HIV scientific meetings such as the Conference on Retroviruses and Opportunistic Infections (CROI), and the International Conference on Antiretroviral Agents and Chemotherapies (ICAAC).

Here at Southwest CARECenter we are committed to providing our clients with premium clinical care, as well as helping to contribute to the body of knowledge that informs cutting edge HIV care. Our medical program offers patients an opportunity to receive outstanding HIV specialty and primary care in a holistic, respectful, supportive environment.